Corneal collagen cross-linking

Corneal collagen cross-linking is intended to slow or halt progressive weakening of the cornea. In keratoconus and other forms of corneal ectasia, the normally dome-shaped cornea becomes thinner, steeper, and more irregular, impairing vision and sometimes producing visual distortion that glasses cannot fully correct. The treatment uses riboflavin, a vitamin B2 derivative, and ultraviolet A light to generate reactive oxygen species that form additional bonds between collagen fibers. The resulting tissue is biomechanically stiffer, although it does not usually restore a previously normal corneal shape. The technique was introduced into clinical practice after experimental and early human work demonstrated increased corneal rigidity. Its principal aim is disease stabilization rather than immediate refractive correction.

Standard treatment removes the corneal epithelium before applying riboflavin and ultraviolet A. After topical anesthesia, the surgeon removes the central epithelial layer, instills riboflavin repeatedly, confirms adequate stromal saturation, and applies a measured ultraviolet A dose while continuing the drops. A bandage contact lens is commonly placed during epithelial healing. The conventional protocol is often called the Dresden protocol, though accelerated and modified schedules are also used. Candidates generally have documented progression on corneal topography, tomography, refraction, or changes in corneal thickness, with sufficient remaining tissue for safe irradiation. Assessment includes mapping both eyes and excluding active infection, severe surface disease, or other factors that increase complications. NICE recognizes cross-linking as a treatment option for progressive keratoconus, while emphasizing specialist selection and follow-up.¹

Cross-linking most reliably stabilizes corneal shape, while visual improvement is variable and often gradual. Studies have generally found reduced progression of keratoconus compared with observation, but the procedure cannot guarantee sharper unaided vision and does not eliminate the need for glasses or contact lenses.² Pain, light sensitivity, tearing, and blurred vision are common for several days while the epithelium heals. Less frequent complications include infectious keratitis, delayed epithelial closure, corneal haze, scarring, and treatment-related loss of corneal clarity. The clinician must account for corneal thickness, ultraviolet exposure, riboflavin penetration, and the possibility of undertreatment or retreatment. Severe, advanced disease may require rigid lenses or, rarely, corneal transplantation rather than cross-linking alone.

Cross-linking is also used in selected cases of post-surgical corneal ectasia, including ectasia after LASIK, although evidence and protocols vary by indication. The epithelium-off approach remains the best-established method because the intact epithelium restricts riboflavin delivery; transepithelial methods seek greater comfort but have shown less consistent biomechanical effects in some studies.³ Treatment may be combined with procedures that reshape the cornea, such as photorefractive techniques, but sequencing and safety depend on stromal thickness. Progression can occur in adolescents and young adults, making long-term surveillance particularly important. Cross-linking is not a cosmetic laser procedure and does not remove the underlying tendency toward ectasia. Research has also examined pulsed light, customized energy delivery, and applications beyond keratoconus, but these remain less standardized than conventional treatment.

Corneal ectasia

Progressive thinning and protrusion of the cornea, occurring in disorders such as keratoconus or after some refractive surgery.

Riboflavin

Vitamin B2 derivative used as a photosensitizer during cross-linking.

Ultraviolet A

Ultraviolet light in the wavelength range used to activate riboflavin in the cornea.

Corneal topography

Mapping of corneal curvature used to detect irregular shape and monitor progression.

Epithelium-off

A technique in which the surface epithelial layer is removed to improve riboflavin penetration.